CVSA (CVSA) Form 144: Director files to sell 7,500 RSUs; prior 10,000-share 10b5-1 sale
Rhea-AI Filing Summary
CVSA filed a Form 144 notice reporting a proposed sale of 7,500 Restricted Stock Units held through Morgan Stanley Smith Barney LLC. The filing also records a prior 10b5-1 sale by Robert Phelan of 10,000 common shares on 05/08/2026 for $1,262,064.69.
The notice lists the securities type as Restricted Stock Units with a grant/vesting date of 08/24/2025 and identifies the broker and exchange information shown in the excerpt.
Positive
- None.
Negative
- None.
Insights
Form 144 documents proposed resale and records a recent 10b5-1 sale.
The filing notifies the market of a proposed sale of 7,500 Restricted Stock Units and discloses a prior 10b5-1 disposition of 10,000 shares on 05/08/2026 for $1,262,064.69. This is a routine regulatory notice required when certain resale conditions apply.
Timing and final execution details for the proposed sale are not present in the excerpt; subsequent filings or broker reports would show completion and cash‑flow treatment.